DK1147212T3 - T-hjælpecelle-epitoper - Google Patents

T-hjælpecelle-epitoper

Info

Publication number
DK1147212T3
DK1147212T3 DK00906047T DK00906047T DK1147212T3 DK 1147212 T3 DK1147212 T3 DK 1147212T3 DK 00906047 T DK00906047 T DK 00906047T DK 00906047 T DK00906047 T DK 00906047T DK 1147212 T3 DK1147212 T3 DK 1147212T3
Authority
DK
Denmark
Prior art keywords
epitopes
helper cell
cell epitopes
sgrrqrrfagvvlagva
fagvvlagvalgvataa
Prior art date
Application number
DK00906047T
Other languages
Danish (da)
English (en)
Inventor
David Charles Jackson
John Walker
Souravi Ghosh
Original Assignee
Univ Melbourne
Csl Ltd
Commw Scient Ind Res Org
Queensland Inst Med Res
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP8533A external-priority patent/AUPP853399A0/en
Priority claimed from AUPQ2013A external-priority patent/AUPQ201399A0/en
Application filed by Univ Melbourne, Csl Ltd, Commw Scient Ind Res Org, Queensland Inst Med Res, Inst Medical W & E Hall filed Critical Univ Melbourne
Application granted granted Critical
Publication of DK1147212T3 publication Critical patent/DK1147212T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00906047T 1999-02-05 2000-02-07 T-hjælpecelle-epitoper DK1147212T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP8533A AUPP853399A0 (en) 1999-02-05 1999-02-05 T helper cell epitopes
AUPQ2013A AUPQ201399A0 (en) 1999-08-04 1999-08-04 T-helper cell epitopes
PCT/AU2000/000070 WO2000046390A1 (fr) 1999-02-05 2000-02-07 Epitopes de lymphocytes t auxiliaires

Publications (1)

Publication Number Publication Date
DK1147212T3 true DK1147212T3 (da) 2010-01-04

Family

ID=25645983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906047T DK1147212T3 (da) 1999-02-05 2000-02-07 T-hjælpecelle-epitoper

Country Status (15)

Country Link
US (5) US6685947B1 (fr)
EP (2) EP1147212B1 (fr)
JP (2) JP4699612B2 (fr)
KR (2) KR100905264B1 (fr)
AT (1) ATE440960T1 (fr)
AU (1) AU765164B2 (fr)
CA (1) CA2361658C (fr)
CY (1) CY1109710T1 (fr)
DE (1) DE60042816D1 (fr)
DK (1) DK1147212T3 (fr)
ES (1) ES2332701T3 (fr)
NZ (1) NZ513482A (fr)
PT (1) PT1147212E (fr)
WO (1) WO2000046390A1 (fr)
ZA (1) ZA200106413B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4699612B2 (ja) * 1999-02-05 2011-06-15 ザ ユニバーシティ オブ メルボーン Ｔヘルパー細胞エピトープ
US20050106137A1 (en) * 2000-05-05 2005-05-19 Stephen Grimes Chimeric peptide immunogens
US20030045467A1 (en) * 2001-01-05 2003-03-06 Tihamer Orban Autoantigen composition
AU2003250586B2 (en) 2002-08-12 2010-09-23 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
BR0313101A (pt) 2002-08-12 2005-06-28 Queensland Inst Med Res Novos lipopeptìdeos imunogênicos que compreendem epitopos de linfócitos t-helper e linfócitos t citotóxicos (ctl), e métodos para sua produção e uso
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
CA2571168A1 (fr) * 2004-06-17 2006-01-26 Mannkind Corporation Variantes ssx-241-49 a caracteristiques de liaison avec mhi-i
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
WO2006026834A1 (fr) 2004-09-10 2006-03-16 The Council Of The Queensland Institute Of Medical Research (Qimr) Formulations de lhrh tronquee
CA2605321A1 (fr) 2005-04-19 2006-10-26 Eli Lilly And Company Anatigenes polysaccharidiens synthetiques monovalents et polyvalents pour intervention immunologique en pathologie
CN101189026A (zh) * 2005-06-01 2008-05-28 辉瑞产品公司 用于治疗尿失禁的疫苗组合物及方法
NZ564359A (en) * 2005-06-17 2011-09-30 Mannkind Corp Analogs of pepetides corresponding to class I MHC-restricted T cell epitopes
SG162817A1 (en) 2005-06-17 2010-07-29 Mannkind Corp Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
WO2007127787A2 (fr) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Lymphocytes t cd4+ de régulation spécifique auto-antigénique de l'insuline
CO2021017322A1 (es) * 2021-12-16 2023-06-20 Univ Cooperativa De Colombia Péptidos inmunogénicos contra el virus distemper canino (cdv)
CN115960262A (zh) * 2022-10-19 2023-04-14 四川农业大学 展示cdv抗原表位的犬细小病毒样颗粒及构建方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047238A (en) 1983-06-15 1991-09-10 American Home Products Corporation Adjuvants for vaccines
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
US5756102A (en) * 1990-11-20 1998-05-26 Virogenetics Corporation Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants
EP0961793A4 (fr) 1997-02-11 2000-09-06 Council Of The Queensland Polymeres dans lesquels sont incorpores des peptides
JP4699612B2 (ja) * 1999-02-05 2011-06-15 ザ ユニバーシティ オブ メルボーン Ｔヘルパー細胞エピトープ

Also Published As

Publication number Publication date
US6685947B1 (en) 2004-02-03
CA2361658A1 (fr) 2000-08-10
KR20090015892A (ko) 2009-02-12
KR20010101796A (ko) 2001-11-14
US7097844B2 (en) 2006-08-29
US20050037014A1 (en) 2005-02-17
CY1109710T1 (el) 2014-08-13
EP1147212A4 (fr) 2004-03-31
EP1147212B1 (fr) 2009-08-26
US7241448B2 (en) 2007-07-10
ES2332701T3 (es) 2010-02-11
US7037507B2 (en) 2006-05-02
PT1147212E (pt) 2009-12-03
US7572454B2 (en) 2009-08-11
JP2002536384A (ja) 2002-10-29
AU765164B2 (en) 2003-09-11
JP4699612B2 (ja) 2011-06-15
WO2000046390A1 (fr) 2000-08-10
ATE440960T1 (de) 2009-09-15
DE60042816D1 (de) 2009-10-08
EP2103691A1 (fr) 2009-09-23
US20050186220A1 (en) 2005-08-25
KR100955668B1 (ko) 2010-05-06
US20070248615A1 (en) 2007-10-25
CA2361658C (fr) 2013-04-09
ZA200106413B (en) 2002-08-05
AU2783600A (en) 2000-08-25
US20060199177A1 (en) 2006-09-07
KR100905264B1 (ko) 2009-06-29
EP1147212A1 (fr) 2001-10-24
JP2011121965A (ja) 2011-06-23
NZ513482A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
CY1109710T1 (el) Επιτοπα βοηθητικων τ λεμφοκυτταρων
TR199900267T2 (xx) GnRH-L�kotoksin kimeralar�.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
NO20002800D0 (no) Cyklosporinholdig mikroemulsjon, forkonsentratsammensetning
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
DK1353689T3 (da) Immuniseringspræparater og anvendelse deraf
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
NL1010321A1 (nl) Wafeldrager.
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
TR200000152T2 (tr) Yeni bileşikler.
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
GB2301591A (en) Cytotoxic T-cell epitopes
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
NO20073914L (no) Biologisk aktive peptider
SE9802937D0 (sv) Novel compounds
DE69426121D1 (de) Gen grb3-3, variante und ihre verwendungen
NO971997D0 (no) Bruk av immunmodulerende midler
IL139604A0 (en) Novel peptides
DE69637243D1 (de) Atelocollagen enthaltende gen-zusammensetzungen
FI943069A7 (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
DE69836485D1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ES2218796T3 (es) Uso de un compuesto peptidico para el tratamiento del lupus erimatoso sistemico.
ATE290538T1 (de) Zusammensetzungen enthaltendes biologisch aktives silizium